Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis

被引:0
作者
Wei-Syun Hu
Cheng-Li Lin
机构
[1] China Medical University,School of Medicine, College of Medicine
[2] China Medical University Hospital,Division of Cardiovascular Medicine, Department of Medicine
[3] China Medical University Hospital,Management Office for Health Data
来源
Internal and Emergency Medicine | 2019年 / 14卷
关键词
Atrial fibrillation; Atrial flutter; Acute kidney injury; Chronic kidney disease; End-stage renal disease;
D O I
暂无
中图分类号
学科分类号
摘要
We investigated the adverse renal outcomes in patients affected by either atrial fibrillation (Afib) or atrial flutter (AFL). Using the Taiwan National Health Insurance research database, both cohorts were 1:1 propensity score matched based on age, sex, index year, and comorbidity using logistic regression model. Hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) of acute kidney injury (AKI), chronic kidney disease (CKD), and end-stage renal disease (ESRD) between the two cohorts were obtained using Cox proportional hazard regression models. Competing-risks regression models were applied to calculate the subhazard ratios (SHRs) and corresponding 95% CIs of the adverse renal outcomes. Afib patients were 1.15 and 1.33 times more likely to experience CKD and ESRD, respectively, than AFL patients (incidence rate per 10,000 person-years (IR): CKD, 10.8 vs 9.41; ESRD, 4.44 vs 3.34), with the adjusted HRs of 1.18 and 1.32 (CKD, 95% CI = 1.07–1.30; ESRD, 95% CI = 1.12–1.55). Afib patients were 1.08 times (95% CI = 1.01–1.16) more likely to have AKI than AFL patients after adjusting for confounding covariates. Competing risk analysis showed that Afib patients were 1.08 (95% CI = 1.01–1.15), 1.18 (95% CI = 1.07–1.30) and 1.32 (95% CI = 1.12–1.55) times more likely to experience AKI, CKD and ESRD than AFL subjects. This study showed that Afib conferred worse renal events of AKI, CKD and ESRD than AFL.
引用
收藏
页码:1113 / 1118
页数:5
相关论文
共 115 条
[1]  
January CT(2014)AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 2014 e1-e76
[2]  
Wann LS(2012)focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation: developed with the special contribution of the European Heart Rhythm Association Eur Heart J 2012 2719-2747
[3]  
Alpert JS(2004)Clinical practice: newly diagnosed atrial fibrillation N Engl J Med 351 2408-2416
[4]  
Calkins H(2002)A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 359-364
[5]  
Cigarroa JE(2009)Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study Am Heart J 158 629-636
[6]  
Cleveland JC(2013)Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease Circulation 127 569-574
[7]  
Camm AJ(2018)Non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and end-stage renal disease Am J Cardiol 121 131-140
[8]  
Lip GY(2018)Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation Nephrol Dial Transplant 33 1683-1689
[9]  
De Caterina R(2019)Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort study Intern Emerg Med 14 71-76
[10]  
Savelieva I(2019)Comparison of CHA2DS2-VASc and AHEAD scores for the prediction of incident dementia in patients hospitalized for heart failure: a nationwide cohort study Intern Emerg Med 14 395-402